Analyst Research: Salix Pharmaceuticals Ltd (SLXP.OQ)

SLXP.OQ on NASDAQ Stock Exchange Global Select Market

59.33USD
4:00pm EDT
Price Change (% chg)

$0.58 (+0.99%)
Prev Close
$59.28
Open
$58.91
Day's High
$59.56
Day's Low
$58.91
Volume
153,300
Avg. Vol
162,602
52-wk High
$60.13
52-wk Low
$37.55

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - SALIX PHARMACEUTICALS, LTD. (SLXP-O) 7:05am EDT Thomson Reuters Stock Report 12 25.00
Salix Pharmaceuticals 18 May 2013 S&P Capital IQ – STARS Reports 10 115.00
SALIX PHARMACEUTICALS LTD DE (SLXP) 12-months forecast 17 May 2013 Pechala's Reports 1 15.00
Salix Pharmaceuticals Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 17 May 2013 Reuters Investment Profile 12 20.00
ValuEngine Detailed Valuation Report for SLXP 15 May 2013 ValuEngine, Inc. 11 127.00
TheStreet.com Ratings Stock Report For: SALIX PHARMACEUTICALS LTD 11 May 2013 TheStreet.com Ratings 5 10.00
Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of SALIX PHARMACEUTICALS LTD including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 2 May 2013 Jefferson Research 11 20.00
 

People

Name Age Since Current Position

Thomas D'Alonzo

 66 2010 Independent Chairman of the Board

Carolyn Logan

 64 2002 President, Chief Executive Officer, Director

Adam Derbyshire

 47 2009 Chief Financial Officer, Executive Vice President - Finance and Administration

William Forbes

 51 2010 Executive Vice President - Research and Development, CMO, Chief Development Officer

Rick Scruggs

 53 2011 Executive Vice President - Business Development
» More People

Salix Pharmaceuticals Ltd News

Search Stocks